secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2022-02-17T23:59:59+00:00
Accession:  0001140361-22-005873
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

First Wave BioPharma receives Nasdaq extension to May 2022; appoints Sarah Romano as CFO
--------------------------------------------------------------------------------

- Nasdaq granted extension through May 25, 2022 to regain compliance with minimum stockholders' equity rule.
- If compliance not shown by June 30, 2022 filing, delisting may occur; appeal rights exist.
- CFO Daniel Schneiderman resigns effective Feb 28, 2022; no disagreement with company.
- Sarah Romano appointed CFO effective March 1, 2022; base salary $365k, 150k stock options, annual bonus up to 35%.
- Romano previously CFO of Kiora Pharmaceuticals; employment includes 12-month non-compete.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000114036122005873/0001140361-22-005873-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000114036122005873/brhc10034177_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-22-005873

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer